Boeing
BA
$240.60
+1.57%
The Boeing Company is a major global aerospace and defense corporation operating in three core segments: commercial airplanes, defense, space & security, and global services. It is a duopoly leader in the commercial aviation market alongside Airbus and a key prime contractor for U.S. defense and space programs. The current investor narrative is dominated by the company's ongoing operational turnaround and recovery in commercial airplane deliveries, juxtaposed against persistent safety and quality control overhangs, while its defense segment benefits from heightened geopolitical tensions and a robust Pentagon budget outlook.…
BA
Boeing
$240.60
Related headlines
Investment Opinion: Should I buy BA Today?
Rating: Hold. The core thesis is that Boeing presents a high-risk, high-reward turnaround bet where severe fundamental flaws currently outweigh compelling cyclical recovery signals, warranting caution until profitability stabilizes.
Supporting evidence for a Hold is mixed but leans cautious. Positively, revenue growth is explosive at 57% YoY, and the EV/Sales of 2.28x is in line with sector peers, suggesting no overvaluation. However, the catastrophic profitability metrics (negative operating margin, volatile net income), dangerously high debt-to-equity of 9.98, and deeply negative free cash flow of -$1.88B present overwhelming financial risks. The stock's underperformance vs. the S&P 500 over 3 and 12 months further indicates weak market conviction.
The thesis would upgrade to a Buy if the company demonstrates two consecutive quarters of sustained positive operating income and positive free cash flow generation, signaling the turnaround is taking root. It would downgrade to a Sell if revenue growth decelerates sharply below 10% YoY or if the debt-to-equity ratio worsens further above 11x, indicating financial distress. Relative to its own volatile history and sector peers, the stock is fairly valued on a sales basis but remains overvalued on any earnings-based metric given its lack of consistent profit. The current price reflects a hopeful discount, not a margin of safety.
Sign up to view all
BA 12-Month Price Forecast
Boeing is a binary bet on an uncertain operational turnaround. The bullish revenue trajectory and defense tailwinds are compelling, but they are directly opposed by catastrophic profitability and a precarious financial position. The neutral stance reflects this standoff; the path of least resistance is continued volatility within a range, as the market awaits clearer signs of fundamental healing. The stance would upgrade to bullish on evidence of sustained positive free cash flow and debt reduction. It would downgrade to bearish on any new major safety/quality incident that threatens delivery timelines or on a deterioration in liquidity metrics.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Boeing's 12-month outlook, with a consensus price target around $312.78 and implied upside of +30.0% versus the current price.
Average Target
$312.78
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$192 - $313
Analyst target range
Insufficient analyst coverage data is available from the provided dataset to determine a consensus price target, Buy/Hold/Sell distribution, or implied upside/downside. The data shows only 9 analysts providing estimates for future EPS and revenue, but no explicit price targets or recommendations are listed. This limited coverage, for a company of Boeing's size, is unusual and may indicate that the provided dataset is incomplete. Typically, Boeing is widely covered by major institutions; the absence of this data here prevents a standard consensus analysis. The available institutional ratings from early 2026 show a series of reiterated 'Buy' or 'Outperform' ratings from firms like Jefferies, UBS, Citigroup, and JP Morgan, suggesting a generally bullish institutional sentiment focused on the turnaround and defense budget tailwinds at that time.
Bulls vs Bears: BA Investment Factors
The investment debate for Boeing is a stark battle between a powerful cyclical recovery narrative and severe, persistent fundamental flaws. The bull case is anchored in a robust 57% revenue rebound and strong defense tailwinds, while the bear case highlights catastrophic profitability, a leveraged balance sheet, and deep-seated operational issues. Currently, the bear side holds stronger evidence, as the company's financial health (negative FCF, high debt, volatile profits) presents tangible, quantifiable risks that outweigh the promising top-line growth. The single most important tension is whether management can translate the revenue recovery into sustained, high-quality profitability and positive free cash flow to service its massive debt. The resolution of this operational turnaround will ultimately determine if the stock is a value trap or a genuine recovery play.
Bullish
- Strong Defense Budget Tailwinds: Recent news highlights a proposed $1.5 trillion Pentagon budget for 2027, driven by geopolitical tensions. As a major prime contractor, Boeing's defense, space & security segment is positioned for direct revenue growth, providing a crucial counterbalance to commercial segment volatility.
- Spectacular Q4 Revenue Recovery: Q4 2025 revenue surged 57.11% year-over-year to $23.95 billion, a sharp rebound from $15.24 billion. This demonstrates significant operational momentum in commercial airplane deliveries and services, a core pillar of the turnaround narrative.
- Valuation Near Sector Average: With an EV/Sales of 2.28x and a PS ratio of 1.85x, Boeing trades roughly in line with the broader Aerospace & Defense industry (typically 1.5x-2.5x EV/Sales). This suggests the market is not pricing in an excessive premium for the recovery, offering a potential entry point.
- Institutional Sentiment Supportive: Despite incomplete consensus data, recent institutional ratings from early 2026 show reiterated 'Buy' or 'Outperform' ratings from major firms like Jefferies, UBS, and Citigroup. This indicates professional investor confidence in the turnaround story.
Bearish
- Catastrophic Profitability & Margins: Profitability is in crisis. The trailing twelve-month operating margin is -6.05%, and the latest quarterly gross margin was a razor-thin 7.57%. Q4 2025's $8.22B net income was preceded by massive losses in Q3 (-$5.34B) and Q2 (-$611M), indicating extreme earnings volatility and underlying inefficiency.
- Extreme Financial Leverage: The balance sheet is dangerously leveraged with a debt-to-equity ratio of 9.98. This massive debt burden, coupled with deeply negative trailing twelve-month free cash flow of -$1.88 billion, leaves the company dependent on external financing and vulnerable to rising interest rates or a downturn.
- Persistent Safety & Quality Overhang: A decade of safety failures and reputational damage, as highlighted in recent news, continues to plague the commercial segment. This creates regulatory risk, potential delivery delays, and customer hesitancy, directly threatening the core recovery thesis and future order flow.
- High Volatility & Market Underperformance: With a beta of 1.128, BA is more volatile than the market. It has underperformed the S&P 500 by -4.71% over the past year and -6.85% over the past three months, indicating weak relative strength and heightened sensitivity to negative news flow.
BA Technical Analysis
The stock is in a volatile but defined recovery trend, having gained 24.33% over the past year. With a current price of $227.38, it is trading approximately 33% above its 52-week low of $176.77 and about 11% below its 52-week high of $254.35, positioning it in the upper-middle portion of its annual range, suggesting momentum but not extreme overextension. Recent short-term momentum is positive but shows signs of divergence; the stock gained 9.68% over the past month, yet is down 2.71% over the past three months, indicating the rally from the March lows near $190 has faced resistance and consolidation. The stock's beta of 1.128 indicates it is moderately more volatile than the broader market, which is typical for a company with Boeing's operational and cyclical sensitivities. Key technical support is anchored at the 52-week low area near $177, while immediate resistance sits at the 52-week high of $254; a sustained breakout above $254 would signal a resumption of the primary uptrend, while a breakdown below $200 would suggest the recovery is faltering.
Beta
1.21
1.21x market volatility
Max Drawdown
-25.0%
Largest decline past year
52-Week Range
$177-$254
Price range past year
Annual Return
+18.3%
Cumulative gain past year
| Period | BA Return | S&P 500 |
|---|---|---|
| 1m | +8.3% | +8.2% |
| 3m | +0.5% | +9.0% |
| 6m | +23.7% | +10.5% |
| 1y | +18.3% | +26.5% |
| ytd | +5.6% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BA Fundamental Analysis
Revenue growth has been volatile but showed a significant year-over-year surge of 57.11% in the latest quarter (Q4 2025), reaching $23.95 billion, a sharp recovery from the $15.24 billion in the year-ago quarter. However, this masks extreme quarterly volatility, as evidenced by the preceding Q3 2025 revenue of $23.27 billion which followed a deeply negative gross profit. Profitability remains the central challenge; while the company reported net income of $8.22 billion in Q4 2025, this was preceded by substantial losses in Q3 2025 (-$5.34 billion) and Q2 2025 (-$611 million). Gross margin for the latest quarter was a thin 7.57%, and the trailing twelve-month operating margin is deeply negative at -6.05%, highlighting severe underlying operational inefficiencies. The balance sheet is highly leveraged with a debt-to-equity ratio of 9.98, indicating significant financial risk. Cash flow generation is weak, with trailing twelve-month free cash flow deeply negative at -$1.88 billion, and the current ratio of 1.19 suggests adequate but not robust short-term liquidity, meaning the company remains dependent on external financing and asset sales to manage its substantial debt load.
Quarterly Revenue
$23.9B
2025-12
Revenue YoY Growth
+0.57%
YoY Comparison
Gross Margin
+0.07%
Latest Quarter
Free Cash Flow
$-1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BA Overvalued?
Given the company's erratic profitability, the Price-to-Sales (PS) ratio is a more stable primary valuation metric. Boeing trades at a trailing PS ratio of 1.85 and an Enterprise Value-to-Sales (EV/Sales) of 2.28. Compared to the broader Aerospace & Defense industry, which often trades at EV/Sales multiples between 1.5x and 2.5x, Boeing's valuation appears roughly in line with the sector, neither commanding a significant premium nor a deep discount. Historically, Boeing's own valuation has been highly volatile; its current PS ratio of 1.85 sits well below the 6.96 level seen just a quarter prior (Q4 2025), indicating a massive de-rating as the market grapples with the sustainability of its recent quarterly profit. This places the stock near the lower end of its own recent historical valuation band, which could reflect either a value opportunity if operations stabilize or a justified discount due to persistent fundamental risks.
PE
74.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -1629x~106x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on profitability and leverage. The company's operating margin of -6.05% and gross margin of 4.79% (TTM) reveal deep inefficiencies, while quarterly results swing wildly from a $8.22B profit to a $5.34B loss. With a debt-to-equity ratio of 9.98 and negative free cash flow of -$1.88B, Boeing is burning cash and reliant on external financing, creating vulnerability to credit market tightening. Revenue, though recovering, remains volatile and heavily concentrated in the cyclical commercial aerospace duopoly, exposing it to order cancellations during downturns.
Market & Competitive Risks include valuation compression and geopolitical sensitivity. Trading at a forward P/E of 52.5x, the stock carries a high growth expectation premium that could compress if earnings fail to stabilize. The beta of 1.128 confirms its sensitivity to market swings and news flow. Geopolitical events, as seen in recent Iran-related news, drive headline volatility for defense stocks, while the commercial segment faces relentless competition from Airbus and reputational damage from safety issues that could lead to market share loss and regulatory scrutiny.
Worst-Case Scenario involves a 'perfect storm' where a new major safety incident triggers regulatory grounding of key models, leading to delivery halts, order cancellations, and massive cash outflows for penalties and fixes. Concurrently, a defense budget cut or program cancellation removes the segment's support. This could force a dilutive equity raise or debt restructuring under duress. The realistic downside is significant; a return to the 52-week low of $176.77 from the current $227.38 represents a loss of approximately -22%. Given the operational fragility, a break below that level toward $150 (-34%) is plausible in an adverse scenario, especially if the max drawdown of -24.96% seen recently repeats or worsens.
FAQ
The key risks are, in order of severity: 1) Operational & Financial Risk: Persistently negative profitability (Operating Margin: -6.05%) and free cash flow (-$1.88B) coupled with extreme leverage (Debt/Equity: 9.98) threaten solvency in a downturn. 2) Safety & Regulatory Risk: A new major safety incident could ground aircraft, halt deliveries, and incur massive costs, derailing the recovery. 3) Cyclical & Competitive Risk: The commercial business is tied to the economic cycle and faces fierce competition from Airbus, risking order book erosion. 4) Geopolitical Risk: While defense is a tailwind, the stock is volatile on geopolitical news, and shifts in U.S. foreign policy could impact long-term contract flows.
Our 12-month outlook presents three scenarios. The Base Case (50% probability) sees a volatile range between $200 and $240, as the company makes slow, uneven progress. The Bull Case (25% probability), fueled by a successful turnaround, targets $254 to $280. The Bear Case (25% probability), triggered by operational setbacks, sees a drop to $177-$190, retesting the 52-week low. The Base Case is most likely, implying the stock may struggle to make decisive upward progress until profitability meaningfully improves.
BA's valuation sends mixed signals. On a Price-to-Sales basis (1.85x) and EV/Sales (2.28x), it appears fairly valued relative to the Aerospace & Defense sector. However, on earnings-based metrics, it looks extremely overvalued, with a trailing P/E of 74 and a forward P/E of 52.5, reflecting a market pricing in a dramatic future profit recovery that has not yet materialized. The valuation implies the market expects a successful turnaround; if that fails, the stock is overvalued. If it succeeds, today's price could be seen as a discount.
BA is a high-risk, speculative investment rather than a conventionally 'good' buy. For risk-tolerant investors seeking a turnaround story, it offers potential upside tied to a commercial aerospace recovery and defense spending. However, with a debt-to-equity ratio of 9.98, negative free cash flow, and volatile profits, the downside risk is substantial. It could be a good buy for a small, speculative portion of a portfolio if you believe management can execute the operational fix, but it is not suitable for conservative investors or those seeking stability.
BA is unsuitable for short-term trading due to its high beta (1.128) and sensitivity to unpredictable news (earnings volatility, geopolitical events, safety headlines). For long-term investors, it is a speculative, multi-year turnaround bet. The operational and financial repair required will take years, not quarters. Therefore, a minimum holding period of 3-5 years is necessary to see if the thesis plays out. It is not an income investment (dividend yield is 0.2%), so the entire return depends on capital appreciation from a successful recovery.